77840263
Oct 2, 2009
SHIONOGI INC.
Subscribe
Pharmaceutical Products, in the Form of an Extended Release Oral Dosage for the Treatment of Hypertension, Attention Deficit Hyperactivity Disorders and Other Disorders Characterized by Excessive Autonomic Hyperactivity